SCHEMBL7207201

SCHEMBL7207201

O=C(CC(=O)c1ccc(Cl)cc1Cl)c1cccs1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.70
NPC1 O15118 2/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
KMT2A Q03164 4/20 0.61
MEN1 O00255 3/20 0.61
APOBEC3A P31941 1/20 0.61
APOBEC3G Q9HC16 1/20 0.61
ERCC5 P28715 2/20 0.55
FEN1 P39748 2/20 0.55
ALDH1A1 P00352 5/20 0.53
MAPK1 P28482 1/20 0.53
HIF1A Q16665 1/20 0.53
MAPT P10636 3/20 0.51
GSK3B P49841 1/20 0.50
GAA P10253 1/20 0.50
L3MBTL1 Q9Y468 3/20 0.49
LMNA P02545 3/20 0.49
POLB P06746 2/20 0.49
KDM4E B2RXH2 2/20 0.48
HPGD P15428 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7201699 0.83 L3MBTL1 (0.68) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL7203112 0.82 RAB9A (0.54) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL11755917 0.81 SMN1; SMN2 (0.68) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL711360 0.79 RAB9A (0.75) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL7200564 0.78 RAB9A (0.67) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL7203066 0.78 ERCC5 (0.56) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL7201296 0.77 CTNNB1 (0.55) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL7205497 0.75 MAPT (0.69) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL8154620 0.74 ERCC5 (0.74) RAB9ANPC1SMN1; SMN2ERCC5FEN1
SCHEMBL7202016 0.73 CTNNB1 (0.55) RAB9ANPC1SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6605730-B2 3-(2-Thienyl)-5-phenyl-1H-pyrazole compounds of given formula NIHON BAYER AGROCHEM K.K. (JP) 2003-08-12 US disclosed
US-20030028034-A1 Nematicidal pyrazoles WADA KATSUAKI (JP) 2003-02-06 US disclosed
US-6310049-B1 3-(2-THIENYL),5-(SUBSTITUTED PHENYL)-1H-PYRAZOLES AND 3-(SUBSTITUTED PHENYL),5-(2-THIENYL)-1H-PYRAZOLES OF GIVEN FORMULA; ANTHELMINTICS NIHON BAYER AGROCHEM K.K. (JP) 2001-10-30 US disclosed
EP-1104418-A2 NEMATICIDAL PYRAZOLES NIHON BAYER AGROCHEM K.K. (JP) 2001-06-06 EP disclosed
WO-2000009500-A2 NEMATICIDAL PYRAZOLES NIHON BAYER AGROCHEM K.K. (JP) 2000-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030028034-A1 Nematicidal pyrazoles CBR3, CBR1, CCR4 RAB9A 1643/4885NPC1 395/4885SMN1; SMN2 3988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.